Phenolics, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Jun 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 19, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 21, 2026
- Oct 20 US 12,766,179 Oral Formulations Containing Enriched Polyphenolic Compounds together with a Form of Creatine, a Source of Choline and Trisodium Citrate
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,226,429 | Enteric Coated, Soluble Creatine and Polyethylene Glycol Composition for Enhanced Skeletal Uptake of Oral Creatine In force · Medium confidence | In force | Medium confidence | |
| US 10,231,933 | Enteric Coated, Soluble Creatine and Polyethylene Glycol Composition for Enhanced Skeletal Uptake of Oral Creatine In force · Medium confidence | In force | Medium confidence | |
| US 12,280,067 | Formulations of Creatine and Cyclodextrin Exhibiting Improved Bioavailability In force · Medium confidence | In force | Medium confidence | |
| US 12,766,179 | Oral Formulations Containing Enriched Polyphenolic Compounds together with a Form of Creatine, a Source of Choline and Trisodium Citrate In force · High confidence | In force | High confidence | |
| US 12,543,767 | Oral Supplements Containing Enriched Phenolic Compound Extracts Combined with Organic Acid Sodium Salts, Creatines And/Or Creatine Salts In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 6 no status recorded
Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/339,396 | Jun 22, 2023 | No status recorded | |
| 17/970,819 | Formulations of Creatine and Cyclodextrin Exhibiting Improved Bioavailability | Oct 21, 2022 | Abandoned |
| 12/262,000 | Oct 30, 2008 | No status recorded | |
| 12/183,943 | Jul 31, 2008 | No status recorded | |
| 11/948,622 | Nov 30, 2007 | No status recorded | |
| 11/508,409 | Aug 22, 2006 | No status recorded | |
| 11/179,771 | Jul 12, 2005 | No status recorded |